<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on...

    Outlook Therapeutics is a late clinical-stage b...

    Filing Type:    PU
    Inovalon Holdings, Inc.

    Inovalon Holdings, Inc.

    Inovalon is a leading technology company providing cloud-based platforms empowerin...

    Inovalon is a leading technology company provid...

    Filing Type:    PU
    Midatech Pharma PLC

    Midatech Pharma PLC

    Midatech is an international specialty pharmaceutical company focused on the devel...

    Midatech is an international specialty pharmace...

    Filing Type:    PU
    Fulcrum Therapeutics, Inc.

    Fulcrum Therapeutics, Inc.

    We are a clinical-stage biopharmaceutical company focused on improving the lives o...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Sol-Gel Technologies Ltd.

    Sol-Gel Technologies Ltd.

    Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing...

    Sol-Gel is a clinical-stage specialty pharmaceu...

    Filing Type:    PU
    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...

    Marinus Pharmaceuticals, Inc. is committed to i...

    Filing Type:    PU
    IMV Inc.

    IMV Inc.

    IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunot...

    IMV Inc. is a clinical stage biopharmaceutical ...

    Filing Type:    PU
    MediciNova, Inc.

    MediciNova, Inc.

    MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...

    MediciNova, Inc. is a publicly-traded biopharma...

    Filing Type:    PU
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.